TNF-alpha antagonists (Ensemble Therapeutics)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameTNF-alpha antagonists (Ensemble Therapeutics)

Drug Alias Namesmall molecule macrocyclic TNF-alpha antagonists (Ensemble Discovery)small molecule macrocyclic TNF-alpha antagonists (Ensemble Therapeutics)TNF-alpha antagonists (Ensemble Discovery)Ensemblin macrocycle (Ensemble Therapeutics)E-32224

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTumor necrosis factor receptor superfamily member 1B antagonistsTumor necrosis factor receptor superfamily member 1A inhibitors

TargetsTumor necrosis factor receptor superfamily member 1ATumor necrosis factor receptor superfamily member 1B

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEnsemble Therapeutics Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEnsemble Therapeutics Corp

Active IndicationsN/A

Inactive IndicationsInflammation

Other Information

ATC CodeN/A